Literature DB >> 2959360

Inhibition of tumor metastasis of Lewis lung carcinoma in C57BL/6 mice by intrapleural administration of Lactobacillus casei.

T Matsuzaki1, T Yokokura.   

Abstract

The antimetastatic effect of Lactobacillus casei YIT9018 (LC 9018) against Lewis lung carcinoma (3LL) in C57BL/6 mice was determined. Intrapleural (i.pl.) administration of LC 9018 was effective in inhibiting pulmonary metastasis after s.c. inoculation of 3LL tumors into C57BL/6 mice. The combination of i.pl. and intralesional or i.v. injections of LC 9018 also markedly inhibited pulmonary metastasis in 3LL-bearing mice. The i.pl. administration of LC 9018 into mice induced an increase in the number of thoracic exudate cells (TEC) and the cell population in the TEC was mainly polymorphonuclear leukocytes in the early stage, while macrophages were dominant in the late stage. In addition, in vitro cytolytic activity against 3LL cells and natural killer cell activity of TEC were augmented by the i.pl. administration of LC 9018. Furthermore, i.pl. administration of LC 9018 into the mice rendered their lung macrophages tumoricidal for 3LL cells in vitro. These results show that TEC induced by i.pl. administration of LC 9018 played a key role in the inhibition of metastasis in 3LL-bearing mice.

Entities:  

Mesh:

Year:  1987        PMID: 2959360     DOI: 10.1007/bf00199948

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  14 in total

1.  Intraperitoneal administration of Corynebacterium parvum in patients with ascitic ovarian tumors resistant to chemotherapy: effects on cytotoxicity of tumor-associated macrophages and NK cells.

Authors:  A Mantovani; C Sessa; G Peri; P Allavena; M Introna; N Polentarutti; C Mangioni
Journal:  Int J Cancer       Date:  1981       Impact factor: 7.396

2.  Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells.

Authors:  R B Herberman; M E Nunn; H T Holden; D H Lavrin
Journal:  Int J Cancer       Date:  1975-08-15       Impact factor: 7.396

3.  Antimetastatic effect of Lactobacillus casei YIT9018 (LC 9018) on a highly metastatic variant of B16 melanoma in C57BL/6J mice.

Authors:  T Matsuzaki; T Yokokura; I Azuma
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

4.  Oxygen radical production by peritoneal macrophages and Kupffer cells elicited with Lactobacillus casei.

Authors:  S Hashimoto; K Nomoto; T Matsuzaki; T Yokokura; M Mutai
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

5.  Macrophage activation by Lactobacillus casei in mice.

Authors:  I Kato; T Yokokura; M Mutai
Journal:  Microbiol Immunol       Date:  1983       Impact factor: 1.955

6.  Intrapleural administration of OK432 in cancer patients: augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytes.

Authors:  A Uchida; M Micksche; T Hoshino
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

7.  Control of lung metastasis progression in mice: role of growth kinetics of 3LL Lewis lung carcinoma and host immune reactivity.

Authors:  E Gorelik; S Segal; M Feldman
Journal:  J Natl Cancer Inst       Date:  1980-12       Impact factor: 13.506

8.  Intrapleural administration of OK432 in cancer patients: activation of NK cells and reduction of suppressor cells.

Authors:  A Uchida; M Micksche
Journal:  Int J Cancer       Date:  1983-01-15       Impact factor: 7.396

9.  Augmentation of host resistance to Listeria monocytogenes infection by Lactobacillus casei.

Authors:  K Nomoto; S Miake; S Hashimoto; T Yokokura; M Mutai; Y Yoshikai; K Nomoto
Journal:  J Clin Lab Immunol       Date:  1985-06

10.  Cytotoxic factor production by Kupffer cells elicited with Lactobacillus casei and Corynebacterium parvum.

Authors:  S Hashimoto; Y Seyama; T Yokokura; M Mutai
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

View more
  4 in total

1.  Augmentation of antimetastatic effect on Lewis lung carcinoma (3LL) in C57BL/6 mice by priming with Lactobacillus casei.

Authors:  T Matsuzaki; Y Shimizu; T Yokokura
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

2.  Antitumor effect of intrapleural administration of Lactobacillus casei in mice.

Authors:  T Matsuzaki; T Yokokura; M Mutai
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

3.  Transposon mutagenesis of probiotic Lactobacillus casei identifies asnH, an asparagine synthetase gene involved in its immune-activating capacity.

Authors:  Masahiro Ito; Yun-Gi Kim; Hirokazu Tsuji; Takuya Takahashi; Mayumi Kiwaki; Koji Nomoto; Hirofumi Danbara; Nobuhiko Okada
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

4.  Effect of combined intrapleural administration of Lactobacillus casei (LC9018) and adriamycin on experimental malignant pleurisy in mice.

Authors:  A Tohgo; N G Tanaka; H Okada; Y Osada
Journal:  Jpn J Cancer Res       Date:  1989-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.